New hope for elderly blood cancer patients: cord blood transplant study launches
NCT ID NCT07441967
First seen Mar 09, 2026 · Last updated May 24, 2026 · Updated 10 times
Summary
This study tests a new combination of chemotherapy drugs before a cord blood transplant in 44 patients aged 60-69 with blood cancers. The goal is to see if this approach lowers the risk of death from transplant complications within 180 days. Participants receive the transplant and are monitored for side effects like graft-versus-host disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCIES are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.